Cargando…
CXCR2 signaling regulates KRAS((G12D))-induced autocrine growth of pancreatic cancer
Pharmacological inhibition of RAS, the master regulator of pancreatic ductal adenocarcinoma (PDAC), continues to be a challenge. Mutations in various isoforms of RAS gene, including KRAS are known to upregulate CXC chemokines; however, their precise role in KRAS-driven pancreatic cancer remains uncl...
Autores principales: | Purohit, Abhilasha, Varney, Michelle, Rachagani, Satyanarayana, Ouellette, Michel M., Batra, Surinder K., Singh, Rakesh K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872785/ https://www.ncbi.nlm.nih.gov/pubmed/26771140 http://dx.doi.org/10.18632/oncotarget.6906 |
Ejemplares similares
-
Pathological and functional significance of Semaphorin-5A in pancreatic cancer progression and metastasis
por: Saxena, Sugandha, et al.
Publicado: (2017) -
Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered Kras(G12D);Pdx1-Cre mouse (KC) model
por: Rachagani, Satyanarayana, et al.
Publicado: (2015) -
Activated Kras(G12D) is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin
por: Rachagani, S, et al.
Publicado: (2011) -
Nicotine/Cigarette-smoke Promotes Metastasis of Pancreatic Cancer Through α7nAChR-mediated MUC4 Up-regulation
por: Momi, Navneet, et al.
Publicado: (2012) -
Semaphorin-5A maintains epithelial phenotype of malignant pancreatic cancer cells
por: Saxena, Sugandha, et al.
Publicado: (2018)